Skip to main content
SpringerLink
Log in

Digitoxin and its metabolites in patients with liver cirrhosis

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Pharmacokinetic profile and urinary excretion of digitoxin and 4 metabolites were investigated in 9 patients with biopsy confirmed liver cirrhosis (median antipyrine clearance 20.0±5.4 ml/min; X±SEM) and were compared with that of 8 healthy volunteers (antipyrine clearance 36.9±4.9 ml/min) following intravenous and p.o. administration of 1 mg digitoxin. The kinetic parameters derived from the digitoxin plasma concentration time curve and from urinary recovery including total clearance of unchanged digitoxin did not differ significantly between both groups investigated. Renal clearance of digitoxin was 0.017±0.005 ml/min/kg in the patient group and 0.011±0.002 ml/min/kg in the volunteers (NS); it was 0.00340±0.00047 ml/min/kg and 0.00223±0.00039 ml/min/kg, respectively for digitoxigenin-bis-digitoxoside (NS), 0.00006±0.00001 ml/min/kg and 0.00016±0.00005 ml/min/kg for digitoxigenin-mono-digitoxoside (P<0.05), 0.00041±0.00013 ml/min/kg and 0.00088±0.00032 ml/min/kg for digitoxigenin (P<0.05), 0.00135±0.00049 ml/min/kg and 0.00113±0.00042 ml/min/kg for digoxin (NS). In conclusion, hydrolysis of digitoxin is altered in liver cirrhosis, whereby a significant reduction in the renal clearance and urinary recovery of digitoxigenin-mono-digitoxoside and digitoxigenin was seen in the present study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lukas D.S., Peterson R.E. (1966): Double isotope dilution derivative assay of digitoxin in plasma urine and stools of patients maintained on the drug. J. Clin. Invest., 45, 782–795.

    Article  CAS  PubMed  Google Scholar 

  2. Smith T.W. (1970): Radioimmunoassay for serum digitoxin concentrations: Methodology and clinical experience. J. Pharmacol. Exp. Ther., 175, 352–360.

    CAS  PubMed  Google Scholar 

  3. Storstein L. (1974): Studies on digitalis. I. Renal excretion of digitoxin and its cardioactive metabolites. Clin. Pharmacol. Ther., 16, 14–24.

    CAS  PubMed  Google Scholar 

  4. Storstein L. (1974): Studies on digitalis. II. The influence of renal function on the renal excretion of digitoxin and its cardioactive metabolites. Clin. Pharmacol. Ther., 16, 25–34.

    CAS  PubMed  Google Scholar 

  5. Storstein L. (1976): Studies on digitalis. VII. Influence of nefrotic syndrome on protein binding, pharmacokinetics and renal excretion of digitoxin and cardioactive metabolites. Clin. Pharmacol. Ther., 20, 158–166.

    CAS  PubMed  Google Scholar 

  6. Storstein L. (1977): Studies on digitalis. XI. Digitoxin metabolism in patients with impaired renal function. Clin. Pharmacol. Ther., 21, 536–546.

    CAS  PubMed  Google Scholar 

  7. Gjerdrum K. (1970): Determination of digitalis in blood. Acta. Med. Scand., 187, 371–379.

    Article  CAS  PubMed  Google Scholar 

  8. Gold H., Cattell M., Modell W., Kwit M.T., Kramer M.L., Zahm W. (1944): Clinical studies on digitoxin (digitaline nativelle) with further observations on its use in the single coverage full dose method of digitalization. J. Pharmacol. Exp. Ther., 82, 187–195.

    Google Scholar 

  9. Graves P.E., Fenster P.E., McFarland R.T., Marcus F.I., Perrier D. (1984): Kinetics of digitoxin and the bis- and mono-digitoxosides of digitoxigenin in normal subjects. Clin. Pharmacol. Ther., 36, 601–606.

    CAS  PubMed  Google Scholar 

  10. Lukas D.S. (1971): Some aspects of the distribution and disposition of digitoxin in man. Ann. NY Acad. Sci. USA, 179, 338–361.

    Article  CAS  Google Scholar 

  11. McFarland R.T., Marcus F.I., Fenster P.E., Graves P.E., Perrier D. (1984): Pharmacokinetics and bioavailability of digitoxin by a specific assay. Eur. J. Clin. Pharmacol., 27, 85–89.

    Google Scholar 

  12. Okita G.T., Talso P.J., Curry Jr J.H., Smith Jr F.D., Geiling E.M.K. (1955): Blood level studies of14C-digitoxin in human subjects with cardiac failure. J. Pharmacol. Exp. Ther., 113, 376–382.

    CAS  PubMed  Google Scholar 

  13. Oliver G.C., Parker B.M., Brasfield D.L., Parker C.W. (1968): The measurement of digitoxin in human serum by radioimmunoassay. J. Clin. Invest., 47, 1035–1042.

    CAS  PubMed  Google Scholar 

  14. Graves P.E., Fenster P.E., McFarland R.T., Marcus F.I., Perrier D. (1984): Kinetics of digitoxin and the bis- and mono-digitoxosides of digitoxigenin in renal insufficiency. Clin. Pharmacol. Ther., 36, 607–612.

    CAS  PubMed  Google Scholar 

  15. Storstein L. (1976): Studies on digitalis. V. The influence of impaired renal function, hemodialysis, and drug interaction on serum protein binding of digitoxin and digoxin. Clin. Pharmacol. Ther., 20, 6–14.

    CAS  PubMed  Google Scholar 

  16. Vöhringer H.F., Rietbrock N., Spurny P., Kuhlmann J., Hampl H., Baethke R. (1976): Disposition of digitoxin in renal failure. Clin. Pharmacol. Ther., 19, 387–395.

    PubMed  Google Scholar 

  17. Lahrtz H., Reinhold H.M., Van Zwieten P.A. (1969): Serum-Konzentration und Ausscheidung von3H-Digitoxin beim Menschen unter normalen und pathologischen Bedingungen. Klin. Wschr., 47, 695–700.

    Article  CAS  PubMed  Google Scholar 

  18. Kirch W., Ohnhaus E.E., Dylewicz P., Pabst J., Storstein L. (1986): Bioavailability and elimination of digitoxin in patients with hepatorenal insufficiency. Am. Heart J., 111, 325–329.

    Article  CAS  PubMed  Google Scholar 

  19. Kirch W., Ohnhaus E.E., Pabst J., Storstein L. (1989): Digitoxin in patients with hepatorenal insufficiency after repeated oral administration. Eur. Heart J., 10, 40–47.

    CAS  PubMed  Google Scholar 

  20. Maier C., Kolenda K.D. (1983): Digitoxin bei hepatorenaler Insuffizienz. Dtsch Med. Wschr., 108, 1475–1480.

    Article  CAS  PubMed  Google Scholar 

  21. Santos S.R.C.J., Ohnhaus E.E., Ketteringham N.R., Kirch W. (1987): Simultaneous analysis of digitoxin and clinically relevant metabolites using HPLC (high performance liquid chromatography) and RIA (radioimmunoassay). J. Chromatogr., 419, 155–164.

    Article  CAS  PubMed  Google Scholar 

  22. Ohnhaus E.E., Kirchhof B., Penheim E. (1979): Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital and rifampicin. Clin. Pharmacol. Ther., 25, 591–597.

    CAS  PubMed  Google Scholar 

  23. Wagner J.G. (1975): Fundamentals of Clinical Pharmacokinetics. Hamilton, IL, USA, Drug Inter. Publ.

    Google Scholar 

  24. Ritschel W.A. (1980): Handbook of Basic Pharmacokinetics 2nd edn. Hamilton, IL, USA, Drug Inter. Publ.

    Google Scholar 

  25. Sachs L. (1984): Angewandte Statistik, 6th edn. Berlin, Heidelberg, New York: Springer.

    Google Scholar 

  26. Storstein L., Amlie P.J. (1979): Pharmacokinetics and metabolism in patients with chronic and active hepatitis. In: Rietbrock N., Greeff K. eds. Frankfurt, Schattauer (1978), München, Schatauer, (1979), p. 191.

    Google Scholar 

  27. Zilly W., Richter E., Rietbrock N. (1975): Pharmacokinetics and metabolism of digoxin and β-methyl-digoxin-12a3H in patients with acute hepatitis. Clin. Pharmacol. Ther., 17, 302–309.

    CAS  PubMed  Google Scholar 

  28. Lüllmann H., Peters T. (1971): The cardioactivity of digitoxin metabolites. Eur. J. Pharmacol., 14, 204–205.

    Article  Google Scholar 

  29. Böttcher H., Lüllmann H., Proppe D. (1973): Comparison of digoxin with digitoxin on cat heart lung preparation. Eur. J. Pharmacol., 22, 109–111.

    Article  PubMed  Google Scholar 

  30. Vöhringer H.F., Rietbrock N. (1981): Digitalis therapy in renal failure with special regard to digitoxin. Int. J. Clin. Pharmacol. Ther. Toxicol., 4, 174–184.

    Google Scholar 

  31. Blaschke T.F. (1977): Protein binding and kinetics of drugs in liver disease. Clin. Pharmacokinet., 2, 32–46.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I. Medizinische Klinik, Christian-Albrechts-Universität, Schittenhelmstr. 12, D-2300, Kiel 1, Germany

    A. Nokhodian & W. Kirch

  2. Advanced Center on Clinical Pharmacology, Research Laboratory, Heart Institute-School of Medicine, University of Sao Paulo, Brazil

    S. R. C. J. Santos

Authors
  1. A. Nokhodian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. R. C. J. Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Kirch
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This publication represents part of the doctoral thesis of Mrs A. Schacht, Department of Internal Medicine, Christian-Albrechts-Universität, Kiel, Germany.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nokhodian, A., Santos, S.R.C.J. & Kirch, W. Digitoxin and its metabolites in patients with liver cirrhosis. Eur. J. Drug Metab. Pharmacokinet. 18, 207–213 (1993). https://doi.org/10.1007/BF03188797

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03188797

Keywords

Search

Navigation